HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

2nd International Conference on Orphan Drugs and Rare Diseases

March 13-15, 2025

March 13 -15, 2025 | Rome, Italy

Translational Science

Translational Science

Translational research aims to provide more relevant, usable outcomes that enhance human health directly. The purpose of translational research is to more rapidly and efficiently convert (move) basic science discoveries into practise. Translational science is a branch of research dedicated to deciphering the scientific and operational concepts that underpin each step of the translational process. Rare diseases are a driving force behind medical and pharmacological innovation and improvement. The majority of rare diseases are genetic disorders or atypical manifestations of infectious, immunologic, or oncologic diseases; they all allow researchers to explore the extremes of human pathology and gain insight into normal and abnormal physiology. Drug development has recently shifted its attention to predominantly genetic classification of diseases, allowing for the identification of molecularly defined targets and the creation of targeted therapeutics. Translational research has the potential to transfer promising research into practical new medicines for people suffering from rare diseases.

  • Diagnosis
  • Clinical Trial Design
  • Need for Translational Research
Committee Members
Speaker at Orphan Drugs and Rare Diseases 2025 - Sergey Suchkov

Sergey Suchkov

The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Speaker at Orphan Drugs and Rare Diseases 2025 - Vladlen Slepak

Vladlen Slepak

University of Miami, United States
Speaker at Orphan Drugs and Rare Diseases 2025 - Harsha Rajasimha

Harsha Rajasimha

Jeeva Clinical Trials, Inc, United States
Orphan Drugs 2025 Speakers
Speaker at Orphan Drugs and Rare Diseases 2025 - Vladlen Slepak

Vladlen Slepak

University of Miami, United States
Speaker at Orphan Drugs and Rare Diseases 2025 - Harsha Rajasimha

Harsha Rajasimha

Jeeva Clinical Trials, Inc, United States
Speaker at Orphan Drugs and Rare Diseases 2025 - Sergey Suchkov

Sergey Suchkov

The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Speaker at Orphan Drugs and Rare Diseases 2025 - Melissa Keenan

Melissa Keenan

La Jolla Labs, United States
Tags

Submit your abstract Today

Watsapp